Electrical surgical instrument with optimized power supply and drive
View Patent ↗A surgical instrument includes a surgical end effector operable to effect a surgical procedure when powered, an electric motor operationally connected to the end effector, and a power supply electrically connected to and selectively powering the motor to operate the end effector, the power supply having at least one battery cell with a critical current rate and having a switch that when activated to power the motor, operates the at least one battery cell at a super-critical current rate.
1. A surgical instrument, comprising:
a surgical end effector operable to effect a surgical procedure when powered;
an electric motor operationally connected to the end effector; and
a power supply electrically connected to and selectively powering the motor to operate the end effector, the power supply:
having at least one battery cell with a critical current rate; and
having a switch that when activated to power the motor, operates the at least one battery cell at a super-critical current rate.
2. The instrument according to claim 1 , wherein the motor is operationally connected to at least one actuation assembly of the end effector, the at least one actuation assembly being operable to operate the end effector when it is actuated by activation of the switch to power the motor.
3. The instrument according to claim 1 , wherein the at least one battery cell is selected to operate at the super-critical current rate for an aggregate pulse time of no greater than approximately 300 seconds.
4. The instrument according to claim 1 , wherein:
the at least one battery cell has a positive temperature coefficient device with a PTC threshold; and
the at least one battery cell operates at the super-critical current rate and below said PTC threshold over a super-critical pulse discharge period.
5. The instrument according to claim 2 , wherein the power supply, the motor, and the at least one actuation assembly generate an output force sufficient to move approximately 82 kg over approximately 60 mm in approximately 3 seconds.
6. The instrument according to claim 1 , wherein the at least one battery cell is a lithium-manganese dioxide cell.
7. The instrument according to claim 1 , wherein the power supply has a series connection of between four and six power cells selected from the group consisting of CR123 power cells and CR2 power cells.
8. A surgical instrument, comprising:
a surgical end effector operable to effect a surgical procedure when powered;
an electric motor operationally connected to the end effector; and
a power supply electrically connected to and selectively powering the motor to operate the end effector, the power supply:
having at least one battery cell with a critical current rate; and
having a switch that when activated to power the motor, operates the at least one battery cell at an average current rate above the critical current rate.
9. The instrument according to claim 8 , wherein the motor is operationally connected to at least one actuation assembly of the end effector, the at least one actuation assembly being operable to operate the end effector when actuated by activating the switch of the power supply to power the motor.
10. The instrument according to claim 8 , wherein:
the at least one battery cell has a positive temperature coefficient device with a PTC threshold; and
the at least one battery cell operates above the critical current rate and below the PTC threshold over a super-critical pulse discharge period.
11. The instrument according to claim 9 , wherein the power supply, the motor, and the at least one actuation assembly generate an output force sufficient to move approximately 82 kg over approximately 60 mm in approximately 3 seconds.
12. The instrument according to claim 8 , wherein the at least one battery cell is a lithium-manganese dioxide cell.
13. The instrument according to claim 8 , wherein the power supply has a series connection of between four and six power cells selected from the group consisting of CR123 power cells and CR2 power cells.
14. A surgical instrument, comprising:
a surgical end effector having at least one actuation assembly operable to effect a surgical procedure when powered;
an electric motor operationally connected to the end effector to operate the at least one actuation assembly; and
a power supply electrically connected to the motor and selectively powering the motor to actuate the at least one actuation assembly at least 1 and less than 16 times during a clinical life of at least one of the end effector, the motor, and the power supply, the power supply having at least one battery cell and a switch that, when activated, operates the at least one battery cell at a super-critical current rate to actuate the at least one actuation assembly only between approximately 0.5 seconds and approximately 15 seconds in duration.
15. The instrument according to claim 14 , wherein the power supply, the motor, and the at least one actuation assembly generate an output force sufficient to move approximately 82 kg over approximately 60 mm in approximately 3 seconds.
16. The instrument according to claim 14 , wherein the at least one battery cell is a lithium-manganese dioxide cell.
17. The instrument according to claim 14 , wherein the power supply has a series connection of between four and six power cells selected from the group consisting of CR123 power cells and CR2 power cells.
18. A surgical instrument, comprising:
a surgical end effector having at least one actuation assembly to effect a surgical procedure when actuated;
an electric motor operationally connected to the end effector and having a rated operating voltage; and
a power supply electrically connected to and selectively powering the motor to operate the end effector, the power supply:
having at least one battery cell with a critical current rate;
having a switch that when activated to power the motor, operates the at least one battery cell at a super-critical current rate at any time during at least a portion of a super-critical pulse discharge period; and
operating the motor above the rated operating voltage during the super-critical pulse discharge period.
19. The instrument according to claim 18 , wherein the motor is operationally connected to the at least one actuation assembly of the end effector, the at least one actuation assembly being operable to operate the end effector when it is actuated by activation of the switch to power the motor.
20. The instrument according to claim 19 , wherein, when the power supply is activated to power the motor and actuate the at least one actuation assembly, the at least one battery cell is operated at the super-critical current rate throughout the super-critical pulse discharge period.
21. The instrument according to claim 18 , wherein the super-critical pulse discharge period lasts between approximately 0.5 seconds and approximately 15 seconds.
22. The instrument according to claim 18 , wherein the super-critical pulse discharge period lasts between approximately 1.5 seconds and approximately 4 seconds.
23. The instrument according to claim 18 , wherein the super-critical pulse discharge period lasts approximately 3 seconds.
24. The instrument according to claim 18 , wherein the at least one battery cell is selected to operate at the super-critical current rate for an aggregate pulse time of no greater than approximately 300 seconds.
25. The instrument according to claim 19 , wherein the power supply, the motor, and the at least one actuation assembly generate an output force sufficient to move approximately 82 kg over approximately 60 mm in approximately 3 seconds.
26. The instrument according to claim 18 , wherein the at least one battery cell is a lithium-manganese dioxide cell.
27. The instrument according to claim 18 , wherein the power supply has a series connection of between four and six power cells selected from the group consisting of CR123 power cells and CR2 power cells.